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Abstract
In Pakistan, there are estimated 7-9 million carriers of hepatitis B virus (HBV) with a carrier rate of 3-5%. This article
reviews the available literature about the prevalence, risk factors, awareness status and genotypes of the HBV in
Pakistan by using key words; HBV prevalence, risk factors, awareness status and genotypes in Pakistani population
in PubMed, PakMediNet, Directory of Open Access Journals (DOAJ) and Google Scholar. One hundred and six
different studies published from 1998 to 2010 were included in this study. Weighted mean and standard deviation
were determined for each population group. The percentage of hepatitis B virus infection in general population
was 4.3318% ± 1.644%, healthy blood donors (3.93% ± 1.58%), military recruits (4.276% ± 1.646%), healthcare
persons (3.25% ± 1.202%), pregnant women (5.872% ± 4.984), prisoners (5.75% ± 0.212%), surgical patients (7.397%
± 2.012%), patients with cirrhosis (28.87% ± 11.90%), patients with HCC (22% ± 2.645%), patients with hepatitis
(15.896% ± 14.824%), patients with liver diseases (27.54% ± 6.385%), multiple transfused patients (6.223% ± 2.121%),
opthalmic patients (3.89% ± 1.004%) and users of injectable drugs (14.95% ± 10.536%). Genotype D (63.71%) is the
most prevalent genotype in Pakistani population. Mass vaccination and awareness programs should be initiated on
urgent basis especially in populations with HBV infection rates of more than 5%.
Introduction
Hepatitis B virus (HBV) infection is a major global
health problem [1-3], especially in Asia, Africa, southern
Europe and Latin America [4]. About 2 billion people
are infected with HBV worldwide [2,4,5], and 400 mil-
lion among them are suffering from chronic HBV infec-
tion [6]. Pakistan is highly endemic with HBV [7] with
nine million people infected with HBV [8] and its infec-
t i o nr a t ei so nas t e a d yr i s e[ 9 ] .T h er e a s o nm a yb et h e
lack of proper health facilities, poor economical status
and less public awareness about the transmission of
major communicable diseases including HBV, HCV and
HIV [6].
The clinical course and sequel of chronic hepatitis vary
among individuals. Infection with HBV leads to a wide
spectrum of clinical presentations, ranging from
asymptomatic carrier state to acute self-limiting infection
or fulminant hepatic failure, chronic hepatitis with progres-
sion to cirrhosis, and hepatocellular carcinoma (HCC) [2].
Studies are too limited to give a clear picture of the pre-
valence of HBV at the National level, especially among
otherwise healthy individuals. Most previous studies tar-
geted different small groups of individuals with some clini-
cal indications therefore; these do not accurately reflect
the overall prevalence in Pakistan [7,8]. The present article
briefly presents the prevalence, risk factors associated with
HBV transmission, awareness status and HBV genotypes
prevalent in Pakistani population.
Literature Search and inclusion criteria
Articles were searched in PubMed, PakMediNet, Direc-
tory of Open Access Journals (DOAJ) and Google Scho-
lar by using keywords; Hepatitis B virus in Pakistan,
Prevalence of HBV in Pakistan, HBV in Blood donors,
Hepatitis B virus in general population, HBV in Pakis-
tani healthcare workers, HBV in surgical patients, HBV
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oners, HBV in diseased population in Pakistan, HBV in
injection drug users, epidemiology of HBV in Pakistan,
HBV genotypes in Pakistan and awareness about HBV
in Pakistani population. Two hundreds and twenty nine
different studies (articles/repots) were obtained from the
literature search, out of which 106 published from 1998
to 2010 were included in the present review. Studies full
filling the following criteria were included: 1) Samples
were collected from Pakistani individuals. 2) An obvious
description of the methods of detection of HBV infec-
tion and genotyping. 3) Information about the number
of individuals studied and their residing area were
reported. 4) Studies reporting risk factors and awareness
status in Pakistani population were included to discuss
the HBV prevalence in different population groups.
Analysis
Studies showing percent prevalence of HBV infection in
different population are shown in table 1, 2, 3 and 4,
while table 5 shows the percentage of different geno-
types prevalent in Pakistan. The percent prevalence in
the different population groups are presented in mean ±
standard deviation (with 95% confidence interval).
Formula used for determination of mean prevalence in
each population group
μ=() / Σ xN i
Formula used for determination of standard deviation
(SD) in each population group
 =− ()
= ∑
1 2
1 N
xi
i
N
.
Where “x” is the percent HBV prevalence reported in
each study and “N” is the total number of studies in the
population groups.
HBV prevalence in various population groups
General population (healthy population)
Eleven different studies reported the percent prevalence
rates of hepatitis B virus of in general population as
4.3318% ± 1.644% (2.46%-8.06%) [6-8,10-17], while six
different studies involving healthy recruits showed the
prevalence rate of 4.276% ± 1.646%. [18-23]. HBV preva-
lence of 5.75% ± 0.212% was observed in prisoners
[24,25]. Fourteen different studies showed the preva-
lence rate of 3.93% ± 1.58% in healthy blood donors in
Pakistan [26-39]. HBV prevalence of 9.0% has been
reported in professional blood donors [40]. Two differ-
ent studies showed the prevalence of HBV in health
care workers as 3.25% ± 1.202% [41,42]. Nine studies
showed the HBV prevalence of 5.872% ± 4.984% in
pregnant women [43-51], while two different studies
demonstrated 1.92% ± 0.169% prevalence in children
[52,53]. A very high frequency of ≥12% HBV infection
in pregnant females has been reported in Bahawalpur,
Hyderabad and Rahim Yar Khan regions [47,49,50]. Up
to 21% of the children born of HBV infected females
were infected [47], while Kazmi et al.[ 5 4 ]s h o w e da
high prevalence of 90% in children born of HBV positive
mothers. Quddus et al. [55] showed HBV prevalence of
8.3% in Afghan refuges residing in Pakistan. Anwar
et al. [56] showed a high prevalence rate of HBV that
was 11.65% in female prostitutes in Lahore, Pakistan.
Frequency of viral hepatitis in blood donors is higher in
Bahawalpur as compared to rest of the world [33].
These studies show that Southern Punjab, Interior
Sindh, District Tatta, Kurrum agency and some areas of
Lahore have very high HBV prevalence of >5%, hence
mass vaccination and awareness programs in these areas
on urgent basis is suggested.
Surgical patients
Four different studies showed 7.397% ± 2.012% HBV
prevalence rates in patients undergoing surgery [57-60].
The lack of routine serological screening in Pakistani
hospitals prior to surgery is one of the factors responsi-
ble for increased disease transmission [59]. It is recom-
mended that every case undergoing surgery should be
screened for hepatitis B and C virus infections [61].
Patients with hepatitis, liver diseases, HCC and cirrhosis
Four different studies showed the percent HBV preva-
lence of 28.87% ± 11.90% in patients with cirrhosis
[62-65] while 22% ± 2.645% HBV prevalence was shown
by three different studies in patients with HCC [66-68].
Five studies in patients with hepatitis showed the per-
cent prevalence of 15.896% ± 14.824% [69-73] while
four different studies in patients with different liver dis-
eases showed the prevalence of HBV as 27.54% ±
6.385% [74-77].
Muti-tranfused population (thalassemic and hemophilic
patients)
Thalassemic and hemophilic patients require life-long
blood transfusions, so it is necessary to obtain screened
blood from a reputable source, because the multitrans-
fused population is more prone to blood-borne
pathogens [78]. Four different reports showed percent
HBV infection of 6.223% ± 2.121% in multi-tranfused
population [79-82].
Intravenous drug users (IDU)
Pakistan is estimated to have 4 to 4.8 million drug users
with 180,000 IDUs [83]. Strathdee et al.[ 8 4 ]o b s e r v e d
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2001. Among them Afghan refugees have higher levels
of needle sharing as compared to the local IDUs [85].
Two different reports showed a very high HBV preva-
lence of 14.95% ± 10.536% in injection drug users
[86,87].
Patients with other diseases
Two different reports show the prevalence of HBV in
ophthalmic patients to be 3.89% ± 1.004% [88,89], per-
cent prevalence of HBV was 12.4% in patients on hemo-
dialysis [90], 26% in psychiatric patients [91], 10.2% in
patients advised for liver function tests [92], 1.5% in
patients with dermatoses caused by lichen planus [93]
and 2.02% in orthopedics patients [94]. High prevalence
among psychiatric patients could be due to razor
sharing, facial and armpit shaving from barbers and
carelessness during injuries.
Genotypes
Hepatitis B virus exists in eight different genotypes (A-
H) and its prevalence differs with differs by geography
and ethnicity [95]. Ten different studies (Table 5) con-
ducted at different regions of Pakistan showed that the
most prevalent HBV genotype in Pakistan is genotype D
with overall prevalence rate of 63.71% followed by geno-
type A (10.036%), genotype C (7.55%) and genotype B
(5.335%) while untypable and mixed genotypes were
2.377% and 9.931%, respectively [1,7,8,87,97-102]. The
most detailed study recently conducted by Awan et al.
[96] showed that the most emerging genotype in Pakis-
tani population is genotype C with the prevalence rate
Table 1 Prevalence of HBV in general population, young recruits and prisoners
Population type Region Methods Population
size
HBV
(%)
HBV marker Reference
General
population
Lahore ELISA 992 8.06% HBsAg Nafees et al. [10]
2009
Larkana ICT, ELISA 200 4.8% HBsAg Shaikh et al. [11]
2009
Lahore ICT 203 2.46 HBsAg Tanveer et al. [12]
2008
Karachi ICT, ELISA. 4000 4.5% HBsAg Noorali et al.[ 7 ]
2008
Southern Punjab ICT/ELISA 1821 5.9% HBsAg Mirza et al. [13]
2007
Karachi ICT, ELISA and PCR. 3820 4.5% HBsAg & DNA Hakim et al.[ 8 ]
2008
Islamabad AxSym HBsAg, CORE& AUSAB
MEIA
1300 4% HBsAg, anti HBs, anti
HBc
Alam et al. [6] 2007
Central Punjab ICT, ELISA 2038 4.83% HBsAg Alam et al. [14]
2006
Rawalpindi ELISA 665 3% HBsAg Farooq et al. [15]
2005
Lahore ICT 757 2.6% HBsAg Amin et al. [16]
2004
Karachi ICT, ELISA 200 3% HBsAg Qasmi et al. [17]
2000
Recruitments Rural Areas of Pakistan ICT, ELISA 3320 4.5% HBsAg Azam et al. [18]
2009
Interior Sindh ICT, ELISA 5237 7.39% HBsAg Malik et al. [19]
2008
Recruits from all over
Pakistan
ICT, ELISA 2558 2.8% HBsAg Sherif & Tariq, [20]
2006
Mardan ICT, ELISA 15550 3.24% HBsAg Mirza et al. [21]
2006
All areas of Pakistan ICT, ELISA 4552 4.2% HBsAg Hussain et al. [22]
2005
All areas of Pakistan ICT, ELISA 5371 3.53% HBsAg Ali et al. [23] 2002
Prisoners Karachi ELISA 365 5.9% HBs Ag Kazi et al. [24] 2010
Bahawalpur ICT, ELISA 2086 5.6% HBs Ag Fayyaz et al. [25]
2006
ELISA: Enzume linked immunosorbant assay; HBsAg: hepatitis B surface antigen; ICT: Immuno-chromatographic Test, MEIA: Microparticle Enzyme Immunoassay,
HBsAg: hepatitis B surface antigen.
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cirrhotic patients and is known to be associated with
more severe liver diseases. Moreover, Previous studies
also shows that genotype D have more severe disease,
less responsive to interferon therapy as compared to gen-
otype A and B and have higher HBV DNA levels. This
genotype also has specific viral sequence patterns that
may predict long-term response to lamivudine treatment
[101]. However, further studies are needed to character-
ize prevalence of different genotypes, their relative sever-
ity and treatment response rates in Pakistani population.
Risk factors associated with HBV infection
History of dialysis for more than 2 years is a risk factor
for dialysis patients [90]. Major risk factors for mother
to infant transmission include increasing maternal age,
number of pregnancies, repeated injections and addic-
tion [51]; major risk factors in surgical patients include
re-use of contaminated syringes, contaminated surgical
instruments and blood products [59]; risk factors in
pregnant women (antenatal) include ear and nose prick,
history of jaundice among them or with their partner
[49], history of blood transfusions, history of injections
Table 2 Percent prevalence rates of HBV in Healthy Blood donors
Population type Region Methods Population size HBV positive (%) HBV marker Reference
Healthy Blood Donors Kurram Agency ICT 1300 5.07% HBsAg Bangash et al. [26] 2009
Interior
Sindh
ICT 5345 6.2% HBsAg Mujeeb & Pearce, [27] 2008
Karachi ICT 11459 1.71% HBsAg Nazar et al. [28] 2008
Karachi ICT 688 4.50% HBsAg Azam et al. [29] 2007
Northern areas ICT 8949 3.66% HBsAg Alam & Naeem, [30] 2007
Karachi ICT 21,125 3.3% HBsAg Mujeeb & Pearce, [31] 2007
District Thatta ICT 310 5.81% HBsAg Ishaq et al. [32] 2007
Southern Punjab ICT, ELISA 27938 2.69% HBsAg Khan et al. [33] 2006
Lahore ICT 18216 3.36% HBsAg Sirhindi et al. [34] 2005
Karachi ELISA 351309 2.0% HBsAg Akhtar et al. [35] 2005
Peshawar/
KPK
MEIA 4000 1.9% HBsAg Ahmad et al. [36] 2004
Rawalpindi ICT 580 5.86% HBsAg Mumtaz et al. [37] 2002
Northern Pakistan ELISA 103858 3.3% HBsAg Khattak et al. [38] 2002
Bahawalpur LAT, ICT 345 5.64% HBsAg Fayyaz et al. [39] 2002
LAT: Latex agglutination test.
Table 3 Percent prevalence rates of HBV infection in Healthcare workers, pregnant women and pediatric population
Population type Region Methods Population
size
HBV positive
(%)
HBV marker Reference
Health Care
Personals
Abbottabad ELISA 125 2.4% HBsAg Sarwar et al. [41] 2008
Muzaffarabad RPHA,
ELISA
199 4.1% HBsAg Naz et al. [42] 2002
Pregnant women Karachi ICT 2592 0.34% HBsAg Sheikh, [43] 2009
Swat ICT, ELISA 5607 3.98% HBsAg Khattak et al. [44] 2009
Karachi EIA 5902 4.6% HBsAg Sami et al. [45] 2009
Lahore ICT, ELISA 2439 2.2% HBsAg Batool et al. [46] 2008
Bahawalpur ICT, ELISA 300 12.3% HBsAG, HBeAG, HBcAB,
HBsAB,
Ahmad et al. [47] 2007
Karachi ICT, ELISA 25,482 1.57% HBs Ag Ali & Memon, [48]
2007
Hyderabad ICT, ELISA 103 12.6% HBsAg Yousfani et al. [49]
2006
Rahim Yar
Khan
ELISA 450 12.0% HBsAg Hakeem et al. [50] 2006
Karachi ICT, ELISA 245 3.26% HBsAg Mehnaz et al. [51] 2002
Children Karachi ELISA 3533 1.8% HBsAg Jafri et al. [52] 2006
Lahore RPHA,
ELISA
392 2.04%. HBsAg Khan et al. [53] 1998
EIA: Enzyme Immunoassay, RPHA: Reverse Passive Hemagglutination Technique.
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Population type Region Methods Population
size
HBV
positive(%)
HBV marker Reference
Surgical patients Karachi EIA 496 5.0% HBsAg Moosa et al. [57]
2009
Jacobabad
Sindh
ICT 150 9.33% HBsAg Daudpota & Soomro,
[58] 2008
Karachi ELISA 387 6.5% HBsAg Masood et al. [59]
2005
Karachi Latex method,
ELISA
411 8.76% HBsAg Shirazi et al. [60]
2004
Patients with cirrhosis Saidu Sharif,
Swat
ELISA 110 21.81% HBsAg Khan et al. [62] 2009
Dera Ismail
Khan
ICT 60 46.67% HBsAg Mashud et al. [63]
2004
Lahore ICT, ELISA 94 23% HBsAg, anti-HBcIgG, anti-
HBs, and HBeAg
Khan et al. [64] 2002
Lahore ELISA 50 24% HBsAg Hussain et al. [65]
1998
Patients with Hepatocellular
carcinoma (HCC)
Hyderabad ELISA 200 21.0% HBsAg Ansari et al. [66] 2009
Rawalpindi ICT, ELISA 44 25% anti-HBsAg, anti-HBcAb
antiHBeAb
Mumtaz et al. [67]
2001
Lahore ELISA 30 20% HBsAg Kausar et al. [68]
1998
Patients with hepatitis Rawalpindi ICT 264 9.8% HBsAg Mumtaz & Aftab [69]
2005
Hyderabad/
Jamshoro
ELISA 100 41% anti-HBs
anti-HBc
Almani et al. [70]
2002
Islamabad ELISA 2574 15% HBsAg Tanwani & Ahmad
[71] 2000
Karachi MEIA-Abbott 1225 2% HBsAg Mahmood [72] 2000
Rawalpindi RPHA or
ELISA
4315 11.68% HBsAg Hussain &
Ahmed [73] 1998
Patients of Liver disease Karachi ICT, ELISA,
PCR
5193 32.6% HBsAg Ahmed et al. [74]
2010
Peshawar ICT, ELISA and
PCR.
181 18.23% HBs Ag or DNA Khan [75] 2006
Faisalabad ELISA 100 29% HBsAg Bilal et al. [76] 2006
Hazara
Division
ICT 893 30.35% HBsAg Khan and Rizvi [77]
2003
MTP (Thalassemic &
Hemophiliac Children)
Islamabad ICT, ELISA 251 3.9% HBsAg Burki et al. [79] 2009
Peshawar ELISA 250 8.4% HBsAg Shah et al. [80] 2005
Peshawar ELISA 80 7.591 HBsAg Mohammad et al.
[81] 2003
Peshawar ELISA 40 5% HBsAg Hussain et al. [82]
2003
Ophthalmic Patients Jamshoro/
Hyderabad
ICT 931 4.6% HBsAg Junejo et al. [88]
2009
Dera Ismail
Khan
ICT, ELISA 1130 3.18% HBsAg Ahmad et al. [89]
2006
IDU Peshawar ELISA 250 22.4% HBsAg Alam et al. [86]
2007b
Karachi ELISA 161 7.5% HBsAg Altaf et al. [87] 2007
MTP: Multi-transfused Population, IDU: Injecting drug Users.
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risk factors were intravenous drug abuse [24,25], rural
origin and shaved by barber [25]; in orthopedic patients
common risk factors are previous history of surgery or
blood transfusion [94]. Major risk factors for health care
workers are dental procedures, needle prick and surgical
procedures [41]; most important risk factors for HBV
infection in young recruits were sharing of razors, his-
tory of intravenous injections, jaundice in the subject
and jaundice in family [22]; in children key risk factors
w e r ei n j e c t i o ni nt h ep a s t ,s u r g i c a la n dd e n t a lp r o c e -
dures, blood transfusion, accidental cuts at barber shops
and umbilical cord cut through unsterilized instruments
at home [102]; in thalassaemic children there is a defi-
nite risk factor of repeated blood transfusion [79], while
main risk factors among the obstetrical and gynecologi-
cal population were unsafe surgery, injections and inade-
quately screened blood transfusions [45]. Qureshi et al.
[103] compared male patients suffering from chronic
hepatitis with healthy people as control and found very
strong relationship of the HBV infection with history of
dental treatment, surgery and history of taking injec-
tions. It is established fact that HBsAg does not cross
the placental barrier however; the infection in children/
newborns may occur at the time of birth or soon after
birth. The infants of HBV positive mothers must be vac-
cinated soon after birth and HBIG immediately within
24 hours of birth [54]. Relatively low prevalence in the
female prostitutes (high risk group) reflects the effect of
legal, social and religious constraints in Pakistani society
[56]. Many of the Afghan refuges (most of them are
children) are rag pickers who collect used syringes and
needles dumped outside the hospitals and hence are one
of the most vulnerable groups to viral hepatitis in Paki-
stan [104]. Most of these factors are easily preventable
and need awareness in general population and the
healthcare workers.
Preventive strategies for HBV infection include healthy
blood transfusion services along with safe sex [34], vac-
cination against HBV [40,103], shaving by barbers needs
to be discouraged [103] and better training of healthcare
workers [105]. Paid blood donation should be prohibited
[85]. All patients needing surgery should be screened for
viral hepatitis and there should be separate operation
theatres facilities for these patients [94]. In addition
reuse of razors in many barber shops that may spread
hepatitis in a substantial number of individuals [106]
and must be discouraged. Importantly, the most com-
mon risk factors and modes of HBV transmission in this
country differ in importance in various community
groups [23].
In Turkish population, HLA-A24 and Cw1 has been
associated with low risk for HBV-related chronic liver
disease and HLA- B13, B8, DR7, DR13 and DQ3 were
found associated with high risk for chronic HBV infec-
tion [107]. However, there is no study that describes cel-
lular or molecular mechanism of HBV infection in
Pakistani population.
Table 5 Summaries of the studies conducted on prevalence of HBV genotypes in Pakistan
Authors Region Patients
(n)
Genotype
A
Genotype
B
Genotype
C
Genotype
D
Genotype
E
Genotype
F
Untypable Mixed
Awan et al.
[96] 2010
All areas of
Pakistan
300 43
(14.33%)
54 (18%) 83
(27.66%)
39 (13%) 2 (0.66%) 4 (1.33%) 31
(10.33%)
44
(14.66%)
Ahmed et al.
[97] 2009
Punjab and Sindh 236 2 (0.85%) - 14
(5.93%)
220
(93.22%)
----
Baig et al.
[98] 2009
Karachi 315 65 (20%) - - 219 (70%) - - - 31
(10%)
Noorali et al.
[7] 2008
Karachi 180 - - - 150
(83.33%)
---3 0
(16.66%)
Hakim et al.
[8] 2008
Karachi 180 - - - 151
(83.89%)
---2 9
(16.11%)
*Alam et al.
[99] 2007
Patients from All
four Provinces
110 5 (4.55) 27(24.54%) - 66 (60%) - - 9 (8.18%) 3
(2.73%)
Baig et al.
[100] 2007
Karachi 295 60
(20.34%)
- - 208
(70.51%)
---2 7
(9.15%)
Alam et al.
[86] 2007
KPK 56 15 (8.92%) - - 35 (62.5%) - - - 16
(28.57%)
Abbas et al.
[101] 2006
Karachi 109 - - - 109 (100%) - - - -
Idrees et al.
[1] 2004
Patients from All
four Provinces
112 24
(21.42%)
20
(17.86%)
46
(41.07%)
9 (8.03%) - - 5 (4.46%) 8
(7.14%)
Total 1893 190
(10.03%)
101
(5.335%)
143
(7.55%)
1206
(63.71%)
2 (0.105%) 4 (0.21%) 45
(2.377%)
188
(9.931%)
KPK: Khyber Pakhtunkhwa Province.
*The percentage values are different in the original manuscript as the authors considered the untypable samples as negative for genotype.
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Nasim et al. [108] conducted a questioner bases survey
in Karachi to assess knowledge about viral hepatitis
among college girls and showed that 57% of them do
not have information about transmission of hepatitis B
virus. In another survey [109] at obstetric and gynecol-
ogy clinic at Hyderabad showed that most of the
women (67.76%) know that HBV is a viral disease,
75.20% responded that it affect liver, 33.88% believed
that it could be transmitted by infected blood transfu-
s i o n ,1 7 . 3 5 %b e l i e v e dt h a ti tc o u l db et r a n s m i t t e df r o m
mother to child, 19.0% mentioned sexual intercourse
responsible for HBV infection, while 40.49% and 38.0%
mentioned contaminated needles and un-sterilised
instruments as a source of HBV infection, respectively.
Mengal et al. [110] surveyed nursing students at nursing
school, Bolan medical complex hospital, Quetta and
reported that only 37.2% of them were completely vacci-
nated and 25.0% had not been vaccinated for HBV.
Chaudhry et al. [111] repoted that 97.4% of the barbers
at Islamabad use new blade for every customer but only
38% of them has knowledge about routes of infection of
HBV and HCV. In another study, Waheed et al. [112]
reported that 39.6% of the barbers at Rawalpindi and
Islamabad knew that Hepatitis B and hepatitis C were
viral diseases, 90.7% thought that hepatitis could spread
by blade sharing, 26.6% knew that it can lead to cancer
and 47.8% knew that a vaccine for HBV was available.
Ali et al. [113] reported that 78.8% of the rural popula-
tion of Faisalabad was unaware of viral hepatitis. In
another study, Asif et al. [114] reported that only 17.6%
of the rural population of Nowshera was aware of the
fact that Hepatitis B and C are transmitted by a virus.
Talpur et al. [115] stated that there is significant lack of
knowledge and poor attitude towards HBV and HCV in
surgical patients at Nawabshah area. We suggest aggres-
sive public awareness programs especially in rural areas
and people at high risk to decrease the burden of HBV
infection in Pakistan.
Conclusions
This article reviews prevalence of HBV in different areas
and population groups in Pakistan, along with awareness
status, risk factors and genotypes in Pakistani popula-
tion. Prevalence of HBV infection varies with population
residing in different regions of Pakistan. The present lit-
erature shows that Afghan refuges in Pakistan, IDUs,
professional blood donors, health care professionals,
prisoners, multiple transfused patients, patients with
HCC, psychiatric patients, general population of some
specific areas like Southern Punjab, Interior Sindh, Dis-
trict Tatta, Kurrum agency, Baltistan and some areas of
Lahore have very high HBV prevalence of more than
5%, and there is urgent need of mass vaccination and
awareness programs. Further studies are needed to char-
acterize HBV prevalent in Pakistan at molecular level.
Moreover, both host and viral factors associated with
molecular and cellular mechanism of HBV infection in
Pakistani population needs to be explored.
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